DNA RNA and Cells
4 January 2023
Arugula Sciences Announces Company Launch with FDA Phase 1 Approval for Osteoarthritis Therapy29 December 2022
TransCode Therapeutics Announces FDA Authorization to Proceed with First-In-Human Clinical Trial29 December 2022
Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults29 December 2022
Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate22 December 2022
U.S. FDA Approves Clinical Trial Application for IASO Bio’s BCMA CAR-T CT103A for Relapsed/Refractory Multiple Myeloma21 December 2022
Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses21 December 2022
Alnylam Submits CTA Application for ALN-KHK, an Investigational RNAi Therapeutic for the Treatment of Type 2 Diabetes21 December 2022
Magenta Therapeutics Provides Update for MGTA-117 Phase 1/2 Dose Escalation Clinical Trial21 December 2022
Sirnaomics Announces Interim Data from Phase I Clinical Trial of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors20 December 2022
Entrada Therapeutics Announces Clinical Hold on IND Application for ENTR-601-44 in Duchenne Muscular Dystrophy17 December 2022
Ferring Receives Approval from U.S. FDA for Adstiladrin for High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer15 December 2022
SpliSense Initiates Phase 1/2 Study of SPL84, RNA-Based Therapy, for the Treatment of Cystic Fibrosis15 December 2022
SwanBio Therapeutics Initiates First-in-Human Study of AAV Gene Therapy for Adrenomyeloneuropathy13 December 2022
AvenCell Presents Safety and Efficacy Data from Lead CD123-Directed Universal CAR T Cell Therapy Program at ASH 2022 MeetingNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports